Details of the Drug Formulaction

General Information of Drug Formulation (ID: F04131)

• Formulation Name: Cilostazol 50 mg tablet
• Company: Breckenridge Pharmaceutical

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Cilostazol	(DMZMSCT)	Intermittent claudication	BD40.00	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant